MAY 10, 2017 07:30 AM PDT

Tough Targets. Simple Genotyping. - New Solutions for CRISPR, Mitochondrial Disease, Neurology, and Pharmacogenetic Research

SPONSORED BY: Canon BioMedical
1 1 89

  • Product Manager, Canon Biomedical
      Dana Pfister Sullivan received her Masters in Biotechnology, from Johns Hopkins University, with a focus in molecular targets and drug design. She has worked in various areas of the biotechnology industry, including pharmaceutical, life science, and molecular diagnostic in both research and development as well as commercial. Dana has five years of practical experience at the laboratory bench, and her work has been published in peer-reviewed journals and presented at international conferences. Dana joined Canon BioMedical as Product Manager shortly after the first launch of the Novallele Genotyping Assays. She is passionate about partnering with life scientists and researchers to develop the next wave of biomedical solutions.


    Do you have targets that are difficult to genotype? Are you starting new projects and looking for a fast convenient genotyping solution?

    Whether screening CRISPR clones, exploring pharmacogenetic interactions, detecting mitochondrial disease targets, or distinguishing genotypes for neurological disorders, PCR followed by high-resolution melting (HRM) is a fast, reliable, and inexpensive genotyping method to get the answers you need for your experiments.

    Canon BioMedical has developed a library of common and unique targets for identifying single nucleotide polymorphisms (SNPs), indels, and large deletions. Unlike most other genotyping techniques, HRM analysis can genotype a single sample in an hour. The Novallele™ assays can be run on any HRM-capable thermocycler.

    Attend our session to learn how the Novallele assays can help you with your research.

    Novallele assays are for Research Use Only. Not for use in diagnostic procedures.

    Show Resources
    Loading Comments...